Kenya Confirms Four New Bundibugyo Ebola Cases, Raising Total to Seven

Kenya’s Ministry of Health confirmed four additional cases of Bundibugyo ebolavirus on Saturday, October 17, bringing the national total to seven. Three of the new patients are health workers who treated the country’s first patient on October 3 and 4. The fourth is a male relative of that patient. All four were already under quarantine when they developed symptoms and tested positive at the National Virology Reference Laboratory and the Kenya Medical Research Institute.

The index patient, a Kenyan man who had lived in the Democratic Republic of the Congo for years, arrived in Nairobi by commercial flight on October 3 after traveling through Uganda. He was taken to hospital, tested positive, and died on October 5. Earlier confirmed cases included a 39-year-old male relative and a 65-year-old female relative, both identified while in quarantine. The three health workers are two men and one woman, ages 29, 35, and 32. They have been receiving supportive care at a designated facility. The second and third patients remain stable.

Director-General for Health Patrick Amoth said 128 of 130 listed contacts, or 98.5 percent, have been traced and placed in quarantine. That figure exceeds the 85 percent global benchmark cited for interrupting transmission. The ministry states there is no evidence of community spread and that risk to the general public remains low. No travel, trade, or gathering restrictions have been imposed.

The cases represent the first known infections transmitted inside Kenya. They are linked to the ongoing Bundibugyo outbreak in the Democratic Republic of the Congo, which has recorded more than 9,000 cases and more than 4,300 deaths since May. The 21-day monitoring period for the remaining contacts has not yet ended; additional cases among people already in quarantine remain possible. Health teams continue to search for the two untraced contacts.

Bundibugyo is a less common Ebola species than Zaire but has caused previous outbreaks in Uganda and the Congo. Supportive care is the primary treatment. Kenya’s rapid isolation of contacts and the absence of community cases so far distinguish this cluster from larger regional epidemics. Whether the total stays at seven will be clear only after the full incubation window closes.